{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:29:56Z","timestamp":1793413796341,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The intermediate bacterial microbiota is a heterogeneous group that varies in the severity of the dysbiosis, from minor deficiency to total absence of vaginal <jats:italic>Lactobacillus spp<\/jats:italic>. We treated women with this vaginal dysbiosis in the first trimester of pregnancy using a vaginally applied lactobacilli preparation to restore the normal microbiota in order to delay the preterm delivery rate. Pregnant women with intermediate microbiota of the vagina and a Nugent score of 4 were enrolled in two groups: intermediate vaginal microbiota and a Nugent score of 4 <jats:italic>with<\/jats:italic> lactobacilli (IMLN4) and intermediate vaginal microbiota and a Nugent score of 4 <jats:italic>without<\/jats:italic> lactobacilli (IM0N4), with and without vaginal lactobacilli at baseline, respectively. Half of the women in each group received the treatment. Among women without lactobacilli (the IM0N4 group), the Nugent sore decreased by 4 points only in the women who received treatment, and gestational age at delivery and neonatal birthweight were both significantly higher in the treated subgroup than in the untreated subgroup (<jats:italic>p<\/jats:italic>\u2009=\u20090.047 and <jats:italic>p<\/jats:italic>\u2009=\u20090.016, respectively). This small study found a trend toward a benefit of treatment with vaginal lactobacilli during pregnancy.<\/jats:p>","DOI":"10.1038\/s41598-023-34275-9","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T15:03:33Z","timestamp":1683039813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of vaginal probiotics containing Lactobacillus casei rhamnosus (Lcr regenerans) on vaginal dysbiotic microbiota and pregnancy outcome, prospective, randomized study"],"prefix":"10.1038","volume":"13","author":[{"given":"Ljubomir","family":"Petricevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Rosicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbet","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"34275_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/ije\/dyt251","volume":"43","author":"HK Brown","year":"2014","unstructured":"Brown, H. K., Speechley, K. N., Macnab, J., Natale, R. & Campbell, M. K. Neonatal morbidity associated with late preterm and early term birth: The roles of gestational age and biological determinants of preterm birth. Int. J. Epidemiol. 43, 802\u2013814 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"34275_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mob.2003.339","volume":"189","author":"H Leitich","year":"2003","unstructured":"Leitich, H. et al. Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysis. Am. J. Obstet. Gynecol. 189, 139\u2013147 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34275_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/CMR.4.4.485","volume":"4","author":"CA Spiegel","year":"1991","unstructured":"Spiegel, C. A. Bacterial vaginosis. Clin. Microbiol. Rev. 4, 485\u2013502 (1991).","journal-title":"Clin. Microbiol. Rev."},{"key":"34275_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00404-009-1318-3","volume":"281","author":"L Donati","year":"2010","unstructured":"Donati, L. et al. Vaginal microbial flora and outcome of pregnancy. Arch. Gynecol. Obstet. 281, 589\u2013600 (2010).","journal-title":"Arch. Gynecol. Obstet."},{"key":"34275_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(03)12823-1","volume":"361","author":"A Ugwumadu","year":"2003","unstructured":"Ugwumadu, A., Manyonda, I., Reid, F. & Hay, P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: A randomised controlled trial. Lancet 361, 983\u2013988 (2003).","journal-title":"Lancet"},{"key":"34275_CR6","first-page":"CD000262","volume":"1","author":"P Brocklehurst","year":"2013","unstructured":"Brocklehurst, P., Gordon, A., Heatley, E. & Milan, S. J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. 1, CD000262 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"34275_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.01.002","volume":"21","author":"GG Donders","year":"2007","unstructured":"Donders, G. G. Definition and classification of abnormal vaginal flora. Best Pract. Res. Clin. Obstet. Gynaecol. 21, 355\u2013373 (2007).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"34275_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/0002-9378(92)91368-K","volume":"166","author":"SL Hillier","year":"1992","unstructured":"Hillier, S. L., Krohn, M. A., Nugent, R. P. & Gibbs, R. S. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Vaginal Infections and prematurity Study Group. Am. J. Obstet. Gynecol. 166, 938\u2013944 (1992).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34275_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent, R. P., Krohn, M. A. & Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29, 297\u2013301 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"34275_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bpobgyn.2006.12.005","volume":"21","author":"H Leitich","year":"2007","unstructured":"Leitich, H. & Kiss, H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract. Res. Clin. Obstet. Gynaecol. 21, 375\u2013390 (2007).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"34275_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/bmj.308.6924.295","volume":"308","author":"PE Hay","year":"1994","unstructured":"Hay, P. E. et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 308, 295\u2013298 (1994).","journal-title":"BMJ"},{"key":"34275_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1471-0528.2009.02237.x","volume":"116","author":"GG Donders","year":"2009","unstructured":"Donders, G. G. et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116, 1315\u20131324 (2009).","journal-title":"BJOG"},{"key":"34275_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144181","volume":"10","author":"A Farr","year":"2015","unstructured":"Farr, A. et al. Role of Lactobacillus species in the intermediate vaginal flora based on Nugent score in early pregnancy: A retrospective cohort study. PLoS ONE 10, e0144181 (2015).","journal-title":"PLoS ONE"},{"key":"34275_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1471-0528.2008.01882.x","volume":"115","author":"L Petricevic","year":"2008","unstructured":"Petricevic, L. & Witt, A. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115, 1369\u20131374 (2008).","journal-title":"BJOG"},{"key":"34275_CR15","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1038\/s41598-020-60671-6","volume":"10","author":"JHHM van de Wijgert","year":"2020","unstructured":"van de Wijgert, J. H. H. M. et al. Intermittent lactobacilli-containing vaginal probiotic or metronidazole use to prevent bacterial vaginosis recurrence: A pilot study incorporating microscopy and sequencing. Sci. Rep. 10, 3884 (2020).","journal-title":"Sci. Rep."},{"key":"34275_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.528202","volume":"11","author":"N Di Simone","year":"2020","unstructured":"Di Simone, N. et al. Recent insights on the maternal microbiota: Impact on pregnancy outcomes. Front. Immunol. 11, 528202 (2020).","journal-title":"Front. Immunol."},{"key":"34275_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/nu13010256","volume":"13","author":"\u00cdM P\u00e9rez-Castillo","year":"2021","unstructured":"P\u00e9rez-Castillo, \u00cd. M. et al. Reporting of perinatal outcomes in probiotic randomized controlled trials. A systematic review and meta-analysis. Nutrients 13, 256 (2021).","journal-title":"Nutrients"},{"key":"34275_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ajog.2003.08.020","volume":"190","author":"MA Klebanoff","year":"2004","unstructured":"Klebanoff, M. A. et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am. J. Obstet. Gynecol. 190, 363\u2013370 (2004).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34275_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","volume":"342","author":"RL Goldenberg","year":"2000","unstructured":"Goldenberg, R. L., Hauth, J. C. & Andrews, W. W. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342, 1500\u20131507 (2000).","journal-title":"N. Engl. J. Med."},{"key":"34275_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1067\/S0002-9378(03)00495-2","volume":"189","author":"G Reid","year":"2003","unstructured":"Reid, G. & Bocking, A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am. J. Obstet. Gynecol. 189, 1202\u20131208 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"34275_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12916-017-0999-x","volume":"16","author":"RG Brown","year":"2018","unstructured":"Brown, R. G. et al. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 16, 9 (2018).","journal-title":"BMC Med."},{"key":"34275_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fimmu.2015.00062","volume":"6","author":"S Yang","year":"2015","unstructured":"Yang, S. et al. Is there a role for probiotics in the prevention of preterm birth?. Front. Immunol. 6, 62 (2015).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34275-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T15:04:24Z","timestamp":1683039864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34275-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34275"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34275-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7129"}}